Lupin to buy 21 products of Japan's Shionogi for Rs 1,000 cr

This acquisition marks Lupin's foray into the Japanese branded market in-line with aspirations to build business globally. Kyowa Pharmaceutical Industry, drug major Lupin's Japanese subsidiary, has......

Rosier year-end seen for Indian pharma, thanks to faster US approvals

India's pharmaceutical industry is expected to see sales and profit growth accelerate in the second half of the year, thanks to a pickup in the pace of US. approvals for new drugs, offsetting any......

India may take WTO action against EU over drug clinical trials

India may go to the World Trade Organisation (WTO) if the European Union does not reconsider its decision to suspend the sale of about 700 generic drugs that were approved based on clinical trials......

Novartis sues Cipla over respiratory drug Onbrez

Novartis said it is partnered with generic drugmaker Lupin Ltd to sell the drug in India Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering......